Godrej Agrovet Limited reported a 10% year-on-year growth in consolidated sales for the first quarter of FY27, reaching INR2,852 crore. This growth was achieved despite a challenging operating environment marked by a delayed monsoon and inflationary pressures. Key business segments like Animal Nutrition and Oil Palm demonstrated strong performance, contributing to the overall positive results.
Godrej Agrovet Reports Q1 FY27 Growth
Godrej Agrovet Limited announced its financial results for the first quarter of the financial year 2027, reporting a consolidated sales figure of INR2,852 crore. This represents a significant 10% year-on-year growth, achieved amidst a complex operating landscape characterized by a delayed monsoon and ongoing inflationary pressures stemming from geopolitical tensions.
Segment Performance Highlights
Animal Nutrition and Oil Palm Drive Growth
The company highlighted strong performance in its Animal Nutrition and Oil Palm businesses. These segments benefited from healthy volumes, improved realizations, and enhanced operating efficiencies. The Animal Nutrition business, in particular, saw a 12.6% revenue growth, driven by robust demand and a 15% increase in cattle feed volumes, with profitability seeing a substantial 29% rise in segment results. The Oil Palm business also posted strong growth, with segment revenue increasing by 28.9% and segment results growing by 14.4%, supported by higher CPO and PKO realizations.
Dairy and Foods Show Resilience
The Dairy business delivered double-digit revenue growth, driven by value-added products, with their share increasing from 42% to 49% of sales. Godrej Foods continued to expand its branded portfolio, with branded volumes growing approximately 6% and Yummiez volumes increasing by 22%. However, profitability in these segments was impacted by elevated milk procurement prices and input cost inflation.
Crop Care Faces Headwinds
The stand-alone Crop Care business experienced a decline of 16.2% in segment revenue. This was primarily due to the significant delay in the monsoon and slower kharif sowing, which impacted volumes of key products. The company is focusing on diversification initiatives within this segment, with new products like Ashitaka, Takai, and Ghassnash gaining traction.
Astec LifeSciences Shows Recovery
Astec LifeSciences demonstrated a sustained recovery momentum, achieving EBITDA breakeven compared to an EBITDA loss in the previous year. This improvement was driven by margin expansion and turnaround initiatives.
Strategic Focus and Outlook
Godrej Agrovet maintained its focus on balance sheet efficiency and disciplined capital allocation. The company is also investing in integrating its Oil Palm business further downstream to become a full value-added business, with plans for a refinery and specialty fats production. The management expressed confidence in targeting double-digit growth for the overall business, with more clarity expected by the end of the second quarter.
Source: BSE
